CD8A and myeloid sarcoma: Hence, CD8+ memory T cells expressing RUNX3 together with EOMES and not T-bet display a broad repertoire of MS-associated brain-homing and cytotoxic markers, which further supports the hypothesis that this subset is preferably recruited to the MS brain.